BioPharm America 2012
Biotechs, Pharmas Wrestle with New Roles in Value Chain
By Marie Powers
Friday, September 21, 2012
BOSTON Pharmaceutical companies and, to some extent, big biotechs, could claim they're victims of their own success, according to Doug Cole, general partner of Flagship Ventures, speaking at the BioPharm America 2012 conference in Boston.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.